Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI) (BeCet)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2013 by Waterland Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Christine B Boers-Doets, Waterland Hospital
ClinicalTrials.gov Identifier:
NCT01136005
First received: June 2, 2010
Last updated: June 11, 2013
Last verified: June 2013